Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma

Head and Neck

Volumn 29, Issue 7, 2007, Pages 648-654

  Almadori, Giovanni ^a   Bussu, Francesco ^a   Galli, Jacopo ^a   Limongelli, Attilio ^a   Persichilli, Silvia ^a   Zappacosta, Bruno ^a   Minucci, Angelo ^a   Paludetti, Gaetano ^a   Giardina, Bruno ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chemoprevention; Head and neck; Oxidative damage; Salivary antioxidant system

Indexed keywords

GLUTATHIONE; URIC ACID;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; MALE; MOUTH CANCER; OXIDATIVE STRESS; PHARYNX CANCER; PRIORITY JOURNAL; SALIVA LEVEL; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORIMETRY; FEMALE; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; SALIVA; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL; URIC ACID;

EID: 34547474616     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20579     Document Type: Article

References (53)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Shah JP, Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin 1995;45:352-368.
3. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-194.
4. Narayana A, Vaughan AT, Fisher SG, Reddy SP. Second primary tumors in laryngeal cancer: results of long-term follow-up. Int J Radiat Oncol Biol Phys 1998;42:557-562.
5. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-456.
6. McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237-1243.
7. Almadori G, Bussu F, Galli J, et al. Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer 2002;94:1006-1011.
8. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
9. Almadori G, Cadoni G, Cattani P, et al. Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer 1996;32A:783-788.
10. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 2001;37:477-492.
11. Almadori G, Paludetti G, Cerullo M, Ottaviani F, D'Alatri L. Marijuana smoking as a possible cause of tongue carcinoma in young patients. J Laryngol Otol 1990;104:896-899.
12. Zhang ZF, Morgenstern H, Spitz MR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8:1071-1078.
13. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope 2002;112:1861-1865.
14. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992;267:166-172.
15. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A 1989;86:9697-9701.
16. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997;272:19633-19636.
17. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-370.
18. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 1999;31:261-272.
19. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56.
20. Cerutti PA. Prooxidant states and tumor promotion. Science 1985;227:375-381.
21. Epe B. Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice? Biol Chem 2002;383:467-475.
22. Chen CL, Chi CW, Chang KW, Liu TY. Safrole-like DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history. Carcinogenesis 1999;20:2331-2334.
23. Kaplan I, Engelberg J, Dayan D. The effect of desalivation on 4-nitroquinoline-1-oxide-induced tongue carcinogenesis: a morphometric study of nucleolar organizer regions. J Oral Pathol Med 2001;30:48-52.
24. Homann N, Tillonen J, Meurman JH, et al. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 2000;21:663-668.
25. Stich HF, Anders F. The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. Mutat Res 1989;214:47-61.
26. Nair UJ, Floyd RA, Nair J, Bussachini V, Friesen M, Bartsch H. Formation of reactive oxygen species and of 8-hydroxydeoxyguanosine in DNA in vitro with betel quid ingredients. Chem-Biol Interact 1987;63:157-169.
27. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001;477:7-21.
28. Flagg EW, Coates RJ, Jones DP, et al. Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol 1994;139:453-465.
29. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001;54:356-361.
30. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003;66:1499-1503.
31. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-921.
32. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003;333:19-39.
33. Miller JA, Miller EC. Metabolic activation and reactivity of chemical carcinogens. Mutat Res 1975;33:25-26.
34. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
35. Huang Q, Yu GP, McCormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002;34:224-233.
36. Bosch FX, Ritter D, Enders C, et al. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value. Int J Cancer 2004;111:530-538.
37. Zappacosta B, Persichilli S, De Sole P, Mordente A, Giardina B. Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers. Arch Oral Biol 1999;44:485-488.
38. Ziobro A, Bartosz G. A comparison of the total antioxidant capacity of some human body fluids. Cell Mol Biol Lett 2003;8:415-419.
39. Kondakova I, Lissi EA, Pizarro M. Total reactive antioxidant potential in human saliva of smokers and nonsmokers. Biochem Mol Biol Int 1999;47:911-920.
40. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
41. Roubenoff R. Gout and hyperuricemia. Rheum Dis Clin North Am 1990;16:539-550.
42. Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med 2002;32:268-277.
43. Dickinson DP. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002;13:238-275.
44. Ohshima M, Sato M, Ishikawa M, Maeno M, Otsuka K. Physiologic levels of epidermal growth factor in saliva stimulate cell migration of an oral epithelial cell line, HO-1-N-1. Eur J Oral Sci 2002;110:130-136.
45. Moore S, Calder KA, Miller NJ, Rice-Evans CA. Antioxidant activity of saliva and periodontal disease. Free Radic Res 1994;21:417-425.
46. Mansson-Rahemtulla B, Rahemtulla F, Baldone DC, Pruitt KM, Hjerpe A. Purification and characterization of human salivary peroxidase. Biochemistry 1988;27:233-239.
47. Zappacosta B, Persichilli S, Mordente A, et al. Inhibition of salivary enzymes by cigarette smoke and the protective role of glutathione. Hum Exp Toxicol 2002;21:7-11.
48. Thomas EL, Aune TM. Lactoperoxidase, peroxide, thiocyanate antimicrobial system: correlation of sulfhydryl oxidation with antimicrobial action. Infect Immun 1978;20:456-463.
49. Bird RP, Draper HH, Basrur PK. Effect of malonaldehyde and acetaldehyde on cultured mammalian cells. Production of micronuclei and chromosomal aberrations. Mutat Res 1982;101:237-246.
50. Salaspuro V, Hietala J, Kaihovaara P, Pihlajarinne L, Marvola M, Salaspuro M. Removal of acetaldehyde from saliva by a slow-release buccal tablet of L-cysteine. Int J Cancer 2002;97:361-364.
51. Boyle JO, Mao L, Brennan JA, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994;168:429-432.
52. Nishioka H, Nishi K, Kyokane K. Human saliva inactivates mutagenicity of carcinogens. Mutat Res 1981;85: 323-333.
53. Dayan D, Hirshberg A, Kaplan I, Rotem N, Bodner L. Experimental tongue cancer in desalivated rats. Oral Oncol 1997;33:105-109.